Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MEDROXYPROGESTERONE 5 MG TAB

medroxyprogesterone acetate
$0.1384per EA
Low Outlier

Strength

5 mg/1

Manufacturer

Mylan Pharmaceuticals Inc.

NDC

59762005802

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MEDROXYPROGESTERONE ACETATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA011839

On Market Since

8/20/2018

Pharmacological Classes

Progesterone Congeners
Progestin

Price History

1W

0.0%

1M

+0.0%

3M

-5.6%

6M

-6.3%

1Y

-4.8%

3Y

+1.0%

5Y

+0.4%

All

+4.9%

Generic Alternatives

1 alternative • Same active ingredient

MEDROXYPROGESTERONE 5 MG TAB
Generic
59762005801•Mylan Pharmaceuticals Inc.
$0.1384

Related Drugs

Same classification

NORETHINDRONE 0.35 MG TABLET
Generic
00378727253•Mylan Pharmaceuticals Inc.
$0.0922
per EA
NORETHINDRONE 0.35 MG TABLET
Generic
00378729253•Mylan Pharmaceuticals Inc.
$0.0922
per EA
NORA-BE TABLET
Generic
00480347516•Teva Pharmaceuticals USA Inc.
$0.0922
per EA
LYLEQ 0.35 MG TABLET
Generic
50102030013•Afaxys Pharma, LLC
$0.0922
per EA
CAMILA 0.35 MG TABLET
Generic
51862088403•Mayne Pharma
$0.0922
per EA
ERRIN 0.35 MG TABLET
Generic
51862088603•Mayne Pharma
$0.0922
per EA
NORA-BE TABLET
Generic
52544062928•Actavis Pharma, Inc.
$0.0922
per EA
EMZAHH 0.35 MG TABLET
Generic
59651013628•Aurobindo Pharma Limited
$0.0922
per EA
EMZAHH 0.35 MG TABLET
Generic
59651013688•Aurobindo Pharma Limited
$0.0922
per EA
INCASSIA 0.35 MG TABLET
Generic
65862092528•Aurobindo Pharma Limited
$0.0922
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy